Pediatric common variable immunodeficiency: immunologic and phenotypic associations with switched memory B cells.

Area of Science:

• Immunology
• Pediatric Medicine
• Clinical Research

Background:

• Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by impaired antibody production.
• Low switched memory B cell counts in CVID patients are associated with increased autoimmunity and organ damage.
• Previous research has not exclusively focused on pediatric CVID cases regarding B cell subsets.

Purpose of the Study:

• To investigate the association between switched memory B cell levels and clinical/immunological manifestations of CVID in children.
• To identify distinct risk groups within the pediatric CVID population based on switched memory B cell counts.

Main Methods:

• Retrospective analysis of 45 pediatric CVID patients.
• Categorization into two groups: Group I (<5 switched memory B cells/mL) and Group II (>=5 switched memory B cells/mL).
• Evaluation of CD3+ T-cell and CD19+ B-cell counts, alongside clinical outcomes.

Main Results:

• Group I patients exhibited lower T-cell and B-cell counts compared to Group II.
• Meningitis, sepsis, bronchiectasis, granulomatous lung disease, autoimmune cytopenias, and hematologic malignancies were exclusively observed in Group I.
• A significant correlation was found between low switched memory B cells and severe clinical sequelae in pediatric CVID.

Conclusions:

• Switched memory B cell counts are a critical indicator of disease severity and risk in pediatric CVID.
• Stratifying pediatric CVID patients into high-risk (Group I) and average-risk (Group II) groups can guide targeted surveillance.
• This classification may aid in proactive management and improved patient outcomes in pediatric CVID.